首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >Risk factors for herpes simplex virus-1/2 viremia and clinical outcomes following unmanipulated haploidentical haematopoietic stem cell transplantation
【24h】

Risk factors for herpes simplex virus-1/2 viremia and clinical outcomes following unmanipulated haploidentical haematopoietic stem cell transplantation

机译:单纯疱疹病毒-1 / 2病毒血症的危险因素及临床结果遵循非法寄型血包造血干细胞移植

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Herpes simplex virus (HSV)-1/2 can still be reactivated after allogeneic haematopoietic stem cell transplantation (allo-HSCT) even when the prophylactic acyclovir is used. However, the risk factors for HSV-1/2 viremia and the clinical outcomes following unmanipulated haploidentical HSCT remain unknown.
机译:背景:即使使用预防性Acyclovir,单项性出血干细胞移植(Allo-HSCT)仍然可以重新激活疱疹病毒(HSV)-1 / 2。 然而,HSV-1/2病毒血症的危险因素和临床结果之后的非法寄和寄生HSCT仍然未知。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号